Amanote Research
Register
Sign In
The Effectiveness and Safety of Antifibrotics for the Treatment of Idiopathic Pulmonary Fibrosis: A Retrospective Single Center Analysis
Respirology
- United Kingdom
doi 10.1111/resp.13700_493
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pulmonary
Respiratory Medicine
Date
November 1, 2019
Authors
Unknown
Publisher
Wiley
Related search
Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
A Critical Assessment of Treatment Options for Idiopathic Pulmonary Fibrosis
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Idiopathic Pulmonary Fibrosis: What Is the Best Treatment?
Barcelona Respiratory Network
Cyclosporin a in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
The Pathogenesis of Idiopathic Pulmonary Fibrosis
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Solitary Pulmonary Caseating Granulomas: A 5-Year Retrospective Single-Center Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Etiology and Treatment of Cough in Idiopathic Pulmonary Fibrosis
Respiratory Medicine
Pulmonary
Respiratory Medicine
Prs41 - Cost-Effectiveness of Pirfenidone for the Treatment of Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
FRI0461 Efficacy and Safety of Antifibrotic Agents in Idiopathic Pulmonary Fibrosis
